Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endogenous ouabain (EO) is a steroid hormone that acts as an inhibitor and signaling molecule through binding to the Na⁺/K⁺-ATPase pump. It plays a role in sodium homeostasis, vascular smooth muscle contractility, and blood pressure regulation. Elevated levels are associated with hypertension.
Inhibition of Na⁺/K⁺-ATPase, activation of downstream signaling pathways (e.g., cSrc)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endogenous Ouabain (EO).